相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Statins for atherosclerotic cardiovascular disease prevention in people living with HIV in Thailand: a cost-effectiveness analysis
David C. Boettiger et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2020)
Trends in medication adherence in HIV patients in the US, 2001 to 2012: an observational cohort study
Bora Youn et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2019)
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
Scott M. Grundy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Adherence to Statin Therapy Among US Adults Between 2007 and 2014
Lisandro D. Colantonio et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Clinical Implications of Revised Pooled Cohort Equations for Estimating Atherosclerotic Cardiovascular Disease Risk
Steve Yadlowsky et al.
ANNALS OF INTERNAL MEDICINE (2018)
Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV: Systematic Review and Meta-Analysis
Anoop S. V. Shah et al.
CIRCULATION (2018)
Association of Human Immunodeficiency Virus Infection and Risk of Peripheral Artery Disease
Joshua A. Beckman et al.
CIRCULATION (2018)
Statins and Multiple Noncardiovascular Outcomes Umbrella Review of Meta-analyses of Observational Studies and Randomized Controlled Trials
Yazhou He et al.
ANNALS OF INTERNAL MEDICINE (2018)
Trends in Utilization of Statin Therapy and Contraindicated Statin Use in HIV-Infected Adults Treated With Antiretroviral Therapy From 2007 Through 2015
Robert S. Rosenson et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population
Daniel R. Drozd et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2017)
Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superiority trial
Judith A. Aberg et al.
LANCET HIV (2017)
Assessing and Refining Myocardial Infarction Risk Estimation Among Patients With Human Immunodeficiency Virus A Study by the Centers for AIDS Research Network of Integrated Clinical Systems
Matthew J. Feinstein et al.
JAMA CARDIOLOGY (2017)
Evaluating the Impact and Cost-Effectiveness of Statin Use Guidelines for Primary Prevention of Coronary Heart Disease and Stroke
David J. Heller et al.
CIRCULATION (2017)
Evidence-based review of statin use in patients with HIV on antiretroviral therapy
Daniel B. Chastain et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY (2017)
Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in HIV
Mabel Toribio et al.
AIDS (2017)
An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study
Nina Friis-Moller et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2016)
Cardiovascular Disease Risk Prediction in the HIV Outpatient Study
Angela M. Thompson-Paul et al.
CLINICAL INFECTIOUS DISEASES (2016)
Statin Utilization and Recommendations Among HIV- and HCV-infected Veterans: A Cohort Study
Meredith E. Clement et al.
CLINICAL INFECTIOUS DISEASES (2016)
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses Second Panel on Cost-Effectiveness in Health and Medicine
Gillian D. Sanders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Cardiovascular Disease, Statins, and HIV
Allison Ross Eckard et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
HIV and Cardiovascular Disease: We Need a Mechanism, and We Need a Plan
Matthew S. Freiberg et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease
Ankur Pandya et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
HIV status and the risk of ischemic stroke among men
Jason J. Sico et al.
NEUROLOGY (2015)
Patient-Accessible Tool for Shared Decision Making in Cardiovascular Primary Prevention Balancing Longevity Benefits Against Medication Disutility
Marianna Fontana et al.
CIRCULATION (2014)
Updating Cost-Effectiveness - The Curious Resilience of the $50,000-per-QALY Threshold
Peter J. Neumann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population
Alison J. Rodger et al.
AIDS (2013)
HIV Infection and the Risk of Acute Myocardial Infarction
Matthew S. Freiberg et al.
JAMA INTERNAL MEDICINE (2013)
Everyone under statin?
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2012)
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
B. Mihaylova et al.
LANCET (2012)
Utilization patterns of extended-release niacin in Canada: Analysis of an administrative claims database
Marc Dorais et al.
CANADIAN JOURNAL OF CARDIOLOGY (2010)
Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study
Nina Friis-Moller et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2010)
Cohort profile: The Centers for AIDS Research Network of Integrated Clinical Systems
Mari M. Kitahata et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2008)
Veterans Aging Cohort Study (VACS) - Overview and description
Amy C. Justice et al.
MEDICAL CARE (2006)
The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients:: comparison with observed events in the D:A:D Study
MG Law et al.
HIV MEDICINE (2006)
Long-term persistence in use of statin therapy in elderly patients
JS Benner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
分享论文
